Literature DB >> 15196915

Aminoacylase 1 is a sphingosine kinase 1-interacting protein.

Michael Maceyka1, Victor E Nava, Sheldon Milstien, Sarah Spiegel.   

Abstract

Sphingosine kinase type 1 (SphK1) and its product sphingosine-1-phosphate have been shown to promote cell growth and inhibit apoptosis of tumor cells. In an effort to further understand the regulation of SphK1, we used a yeast two-hybrid screen to find SphK1-interacting proteins. One of these was identified as aminoacylase 1 (Acy1), a metalloenzyme that removes amide-linked acyl groups from amino acids and may play a role in regulating responses to oxidative stress. Both the C-terminal fragment found in the two-hybrid screen and full-length Acy1 co-immunoprecipitate with SphK1. Though both C-terminal and full-length proteins slightly reduce SphK1 activity measured in vitro, the C-terminal fragment inhibits while full-length Acy1 potentiates the effects of SphK1 on proliferation and apoptosis. Interestingly, Acy1 induces redistribution of SphK1 as observed by immunocytochemistry and subcellular fractionation. Collectively, our data suggest that Acy1 physically interacts with SphK1 and may influence its physiological functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196915     DOI: 10.1016/j.febslet.2004.04.093

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

Review 1.  Sphingosine kinase regulation and cardioprotection.

Authors:  Joel S Karliner
Journal:  Cardiovasc Res       Date:  2008-11-18       Impact factor: 10.787

Review 2.  Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress.

Authors:  Joel S Karliner
Journal:  Biochim Biophys Acta       Date:  2012-06-23

Review 3.  Extracellular and intracellular actions of sphingosine-1-phosphate.

Authors:  Graham M Strub; Michael Maceyka; Nitai C Hait; Sheldon Milstien; Sarah Spiegel
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

4.  Differential aminoacylase expression in neuroblastoma.

Authors:  Patrick M Long; Holly M Stradecki; Jane E Minturn; Umadevi V Wesley; Diane M Jaworski
Journal:  Int J Cancer       Date:  2011-04-01       Impact factor: 7.396

Review 5.  Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer.

Authors:  Dmitri Pchejetski; Torsten Böhler; Justin Stebbing; Jonathan Waxman
Journal:  Nat Rev Urol       Date:  2011-09-13       Impact factor: 14.432

6.  Expanding the phenotype in aminoacylase 1 (ACY1) deficiency: characterization of the molecular defect in a 63-year-old woman with generalized dystonia.

Authors:  Jörn Oliver Sass; Jathana Vaithilingam; Corinne Gemperle-Britschgi; Cathérine C S Delnooz; Leo A J Kluijtmans; Bart P C van de Warrenburg; Ron A Wevers
Journal:  Metab Brain Dis       Date:  2015-12-19       Impact factor: 3.584

Review 7.  Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation.

Authors:  Ashley J Snider; K Alexa Orr Gandy; Lina M Obeid
Journal:  Biochimie       Date:  2010-02-13       Impact factor: 4.079

8.  Chain length specificity for activation of cPLA2alpha by C1P: use of the dodecane delivery system to determine lipid-specific effects.

Authors:  Dayanjan S Wijesinghe; Preeti Subramanian; Nadia F Lamour; Luciana B Gentile; Maria H Granado; Alicja Bielawska; Zdzislaw Szulc; Antonio Gomez-Munoz; Charles E Chalfant
Journal:  J Lipid Res       Date:  2008-12-15       Impact factor: 5.922

9.  A proteomic analysis of the ventral hippocampus of rats subjected to maternal separation and escitalopram treatment.

Authors:  Lelanie Marais; Suzél M Hattingh; Dan J Stein; Willie M U Daniels
Journal:  Metab Brain Dis       Date:  2009-10-16       Impact factor: 3.584

10.  Isolated mild intellectual disability expands the aminoacylase 1 phenotype spectrum.

Authors:  Maria G Alessandrì; Manuela Casarano; Ilaria Pezzini; Stefano Doccini; Claudia Nesti; Giovanni Cioni; Roberta Battini
Journal:  JIMD Rep       Date:  2014-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.